Early research (Phase 1)WithdrawnNCT02037282
What this trial is testing
A Phase 1, Open Label, Ascending Dose Cohort Study of the Pharmacokinetics of Anti-Influenza Hyperimmune Intravenous Immunoglobulin in Healthy Subjects
Who this might be right for
InfluenzaFlu
National Institute of Allergy and Infectious Diseases (NIAID)